SITC Cancer Immunotherapy CONNECT

SITC Immuno-oncology Drug Development Summit

SITC Immuno-oncology Drug Development Summit

Join us from Sept. 30–Oct. 1, 2024, in Boston at The Revere Hotel Boston Common. The SITC Immuno-oncology Drug Development Summit will educate the IO community on the regulatory paths for the next wave of IO therapeutics.

View Program Details

2024 ACI Cell Therapy

2024 Advances in Cancer Immunotherapy: A Focus on Cellular therapies, T cell Engagers and TIL Therapies
April 16, 2024 | 1–5 P.M. ET | Live via Zoom 

Understand practical aspects of TIL therapy and obstacles faced by institutions during the clinical trials. FREE for healthcare professionals, students, patients and patient advocates.

Learn More and Register

Target for Cancer IO.png

Targets for Cancer IO: A Deep Dive Series

SITC is pleased to announce its fourth Targets for Cancer IO: A Deep Dive live webinar series.

At the time of registration, if you buy 4 webinars, you get the remaining 3 for free!

REGISTER NOW

SITC Annual Awards

Nominate Colleagues for Annual Awards

Current SITC members can submit nominations for Annual Awards and the Academy of Immuno-Oncology. Nominations are due May 1.

Learn More and nominate

AI in IO.png

AI in IO: SITC-NCI Computational Immuno-oncology Webinar Series

SITC is pleased to announce its fourth SITC-NCI Computational Immuno-oncology Webinar Series.

This year's series will focus specifically on the application of artificial intelligence (AI) in the field of immuno-oncology (IO).

REGISTER NOW

Join or renew your SITC membership for 2024 and 2025 today.


Immunotherapy

Advances in Cancer Immunotherapy™ (ACI) Series

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates.

Explore the 2024 ACI Series
FAIO

Nominate Colleagues for SITC Annual Awards and the Academy of Immuno-Oncology

Submit Nominations by May 1

Current SITC members can nominate colleagues for a host of awards. Pay tribute to someone who has revolutionized the field of immunotherapy and immuno-oncology.

LEARN MORE AND NOMINATE
ACI Toxicity Management

Advances in Cancer Immunotherapy™: A Focus on Toxicity Management

Tuesday, May 14 |11 a.m.–3 p.m. ET Virtual – Zoom

Understand toxicities associated with immune checkpoint inhibitors with insights from an expert panel. FREE for healthcare professionals, students, patients and patient advocates.

REGISTER
SITC Deep Dive

Targets for Cancer IO: 2024 Deep Dive - A Deep Dive into Personalized Vaccines

Live Webinar 2 Starts Wednesday, May 22, 2024, from 12–2 p.m. EDT

Key leaders in the field who are experts in their respective fields will provide an overview of the current state of the science and address questions about its future.

Register Today
ACI Genitourinary

Advances in Cancer Immunotherapy™: A Focus on Genitourinary Cancers

Tuesday, June 11 |11 a.m.–3 p.m. ET Virtual – Zoom

Access the latest developments in immunotherapy for kidney and bladder cancers and rare GU tumors. FREE for healthcare professionals, students, patients and patient advocates.

Explore Program
ACI Lung

Advances in Cancer Immunotherapy™: A Focus on Lung Cancers

Tuesday, June 25 |1–5 p.m. ET
Virtual – Zoom

Program features a discussion on immunotherapy and biomarker-driven lung cancer. FREE for healthcare professionals, students, patients and patient advocates.

View Details
SITC Summit on Immunomodulation of Antibody-drug Conjugates

SITC Summit on Immunomodulation of Antibody-drug Conjugates

Wednesday, June 26, 2024 
11 A.M.–3 P.M.

The free summit will highlight the current understanding of antibody-drug conjugates (ADCs) and their effects on the immune system and the tumor microenvironment.

REGISTER TODAY
ACI Hematologic

Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies

Wednesday, Sept. 11 |1–5 p.m. ET 
Virtual – Zoom

Program addresses how to identify and manage CAR T -associated secondary malignancies. FREE for healthcare professionals, students, patients and patient advocates.

Register
SITC Drug Development Summit

SITC Immuno-oncology Drug Development Summit

Sept. 30 – Oct. 1, 2024 in Boston at The Revere Hotel Boston Common

The SITC Immuno-oncology Drug Development Summit will ensure that active, innovative new therapies are rapidly and appropriately moved into clinical testing.

Learn More
ACI Toxicity Management

Advances in Cancer Immunotherapy™: A Focus on Intratumoral Therapies, Vaccines, & Cytokines

Wednesday, Oct. 9 |11 a.m.–3 p.m. ET Virtual – Zoom

Program features a session on emerging therapies, where the EMERALD trial and FLASH radiotherapy plan to be discussed. 

Explore Program

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events


 Read the Latest SITC News

The following articles have been recommended for further reading in the field of cancer immunotherapy ...
MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven ...

AACR Annual Meeting 2024

The Society for Immunotherapy of Cancer (SITC) is pleased to present highlights of the latest ...

 Latest Discussions

  • Hello, We're excited to announce the upcoming meeting "New Frontiers in Cancer ...

  • Hello! Attached are two flyers for the fourth Targets for Cancer IO: Deep ...

  • Posted in: Women in SITC

    We're thrilled to unveil the faculty lineup for the upcoming 2024 SITC Women ...

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

 Join the SITC Family